Irkutsk Regional Oncology Center

Irkutsk 664035

0 studies enrolling now · 4 studies all time

What they study most

ALK+ Advanced NSCLC, Hepatocellular Carcinoma, Non-Small-Cell Lung Carcinoma, Pancreatic Cancer

Studies at this site

• A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer — Completed
• A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) — Withdrawn before enrolling
• Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer — Completed
• T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients — Stopped early